Merck & Co Stock Price. Everything You Need To Know About The Merck & Co Stock!

What is Merck & Co Stock Price. Everything You Need To Know About The Merck & Co Stock!?

Merck & Co., Inc. is a leading provider of health solutions, including prescription medicines vaccines, biologic therapies, animal health, and consumer care products. Headquartered in Kenilworth, New Jersey, the company has a global workforce of 68,000 full-time employees. Merck & Co., Inc. operates through two primary segments: Pharmaceutical and Animal Health. The Pharmaceutical segment offers a wide range of human health pharmaceutical and vaccine products, including therapeutic and preventive agents for the treatment of various human disorders. These products are primarily sold to drug wholesalers and retailers, hospitals, government agencies, and managed healthcare providers such as health maintenance organizations. Investors can keep track of the company's performance by checking the stock price today and monitoring the share price, which is widely traded on various stock exchanges. Additionally, the company's market cap reflects its position as a major player in the healthcare industry. The Animal Health segment develops, manufactures, and markets a broad range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment, and control of disease in all livestock and companion animal species. Investors can view the stocks share price today in premarket trading, providing them with valuable information to make informed investment decisions. With its focus on developing innovative health solutions, Merck & Co., Inc. continues to be a major player in the healthcare industry.

Merck & Co Stock Price. Everything You Need To Know About The Merck & Co Stock! performance

  • Employees

  • Company HQ

  • Website
  • MRK Asset Type

    Common Stock
  • MRK Market Capitalization

  • Earnings Per Share 1.23
  • Dividends Per Share 2.84
  • Dividend Date 2023-10-06
  • Quarterly Earnings Growth -0.347

How To Invest In Merck & Company Inc Stock From Malaysia, Thailand, Indonesia & Vietnam

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the global stock market? Look no further than Merck & Co, a leading pharmaceutical company with a long-standing track record of success. With its innovative medicines and healthcare products, Merck & Co has become a go-to investment choice for many. But how can you invest in this stock from your country? Zorion, the ultimate investment platform, provides you with the opportunity to invest in real US stocks like Merck & Co, allowing you to diversify your investment portfolio. With Zorion's investment insights and recommendations, along with access to educational resources, you can make informed decisions about your investments. Start investing in Merck & Co today and pave your way to financial success!

How To Buy Merck & Company Inc Stock From Malaysia, Thailand, Indonesia & Vietnam

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further as Zorion is here to help you make informed investment decisions. One stock that you might consider is Merck & Co. As a renowned pharmaceutical company, Merck & Co. offers immense potential for growth and returns. But how can you buy this stock? Zorion provides you with the resources and educational materials necessary to understand the process and make a well-informed decision. Our investment insights and recommendations will guide you on how to buy Merck & Co. stock from Malaysia, Thailand, Indonesia, or Vietnam. Start your investment journey with Zorion today!

Merck & Company Inc Analytics and Performance


Discover Merck & Company Inc (MRK), a prominent player in the LIFE SCIENCES sector, specifically within the PHARMACEUTICAL PREPARATIONS industry. As a Common Stock, MRK has a strong presence not only in the United States but also in various countries around the world, including its home base USA.

MRK Financial Performance: Key Ratios and Market Indicators

As of the latest quarter ending 2023-06-30, MRK boasts an EBITDA of 12327999000 and a trailing price-to-earnings ratio (PE ratio) of 83.7. The forward PE ratio stands at 14.75, which indicates stocks potential in earnings. MRK's price-to-sales ratio (TTM) is 4.713, and the price-to-book ratio is 6.36. The company's enterprise value-to-revenue and enterprise value-to-EBITDA ratios are 5.12 and 13.96, respectively.

MRK Stock Stability: Analyzing Marketing Volatility and Trends

MRK stock performance showcases a beta of 0.334, highlighting moderate volatility. The 52-week high and low prices are 118.05 and 84.68, respectively, with a 50-day moving average of 107.52 and a 200-day moving average of 109.82. With 2537520000 shares outstanding, MRK demonstrates strong performance in the market.

MRK Dividends: Current Yields and Shareholder Value

In terms of dividends, Merck & Company Inc has a dividend per share of 2.84 and a dividend yield of 0.0284. The company's most recent dividend date was 2023-10-06, and the ex-dividend date was 2023-09-14. MRK's financials reveal a book value of 15.24 and earnings per share (EPS) of 1.23, with a diluted EPS (TTM) of 1.23.

MRK Revenue and Profitability: Unveiling the Company's Financial Strength

MRK revenue per share (TTM) is 22.98, and its total revenue (TTM) amounts to 58311000000. The company's gross profit (TTM) is 42077000000. MRK's profit margin stands at 0.0534, while the operating margin (TTM) is 0.149. The return on assets (TTM) and return on equity (TTM) are 0.0512 and 0.0761, respectively.

MRK Growth Prospects: Earnings Growth and Analyst Expectations

MRK has experienced quarterly earnings growth (YOY) of -0.347, but its quarterly revenue growth (YOY) remains stagnant at 0.03. Analysts have set a target price of 124.15 for Merck & Company Inc stock.

Want To Buy Merck & Company Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: